Skip to content
Disclosery

EXANE DERIVATIVES: AMH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AMH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,172 AMH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,172 shares
    Change vs previous 13F -395 shares

    0.08% of the 13F portfolio, value $147,826.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 4,567 shares
    Change vs previous 13F -740 shares

    0.05% of the 13F portfolio, value $182,806.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 5,307 shares
    Change vs previous 13F -1,320 shares

    0.06% of the 13F portfolio, value $231,430.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 6,627 shares
    Change vs previous 13F +74 shares

    0.06% of the 13F portfolio, value $252,612.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,553 shares
    Change vs previous 13F -3,188 shares

    0.06% of the 13F portfolio, value $268,601.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 9,741 shares
    Change vs previous 13F +5,526 shares

    0.1% of the 13F portfolio, value $324,751.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 4,215 shares
    Change vs previous 13F -310 shares

    0.04% of the 13F portfolio, value $126,444.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 4,525 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $128,865.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).